TRPM7 (transient receptor potential cation channel subfamily M member 7) regulates gene expression and stress-induced cytotoxicity and is required in early embryogenesis through organ development. Here, we show that the majority of TRPM7 is localized in abundant intracellular vesicles. These vesicles (M7Vs) are distinct from endosomes, lysosomes, and other familiar vesicles or organelles. , an ion channel and cytoplasmic kinase, is ubiquitously expressed and essential in early embryonic development (1-4) but also may mediate oxidative stress-induced anoxic neuronal death in adults (5, 6). As an ion channel, TRPM7 conducts Zn 2+ >Mg 2+ ∼ Ca 2+ and monovalent cations (7-10) and contributes to labile cytosolic and nuclear Zn 2+ concentrations (8). TRPM7's C-terminal kinase can phosphorylate multiple substrates (11-13) and is cleaved to release a proapoptotic, chromatin-modifying enzyme (8, 14) . Zn 2+ regulates TRPM7's kinase activity (11) and binding to transcription factors (8). It is a potent signal for many cellular processes previously related to TRPM7 function, including gene expression, mitosis, and cell survival, but is also proapoptotic at extreme concentrations (15) (16) (17) (18) Oxidative stress increases inward divalent ion permeation through TRPM7 (5, 9), whereas acute and chronic oxidative stress in culture (24-26) or during ischemia-reperfusion in vivo (27, 28) induces TRPM7 expression. The resulting increase in cytosolic Zn 2+ could result in toxic cytosolic concentrations (9). Conversely, reduction of TRPM7 expression protects animals from postischemia reperfusion (5), a condition typically accompanied by increased reactive oxygen species (ROS) and Zn 2+ release from intracellular stores (29). Physiological redox transitions required for stem cell differentiation and gene expression during embryonic development (30, 31) may also be sensed by TRPM7 and transduced via Zn -dependent signals (32). Because TRPM7 patch-clamp recording is limited to the plasma membrane, the assumption has been that TRPM7's main function is on the plasma membrane. However, we have previously shown that TRPM7 is also on intracellular membranes (33-35). Indeed, ROS activation of divalent ion influx through TRPM7 (5, 9) is reminiscent of ROS activation of TRPM2, which releases Ca 2+ and Zn 2+ from lysosomes (36, 37 ] and ROS during development and injury.
TRPM7 (transient receptor potential cation channel subfamily M member 7) regulates gene expression and stress-induced cytotoxicity and is required in early embryogenesis through organ development. Here, we show that the majority of TRPM7 is localized in abundant intracellular vesicles. These vesicles (M7Vs) are distinct from endosomes, lysosomes, and other familiar vesicles or organelles. M7Vs accumulate Zn 2+ in a glutathione-enriched, reduced lumen when cytosolic Zn 2+ concentrations are elevated. Treatments that increase reactive oxygen species (ROS) trigger TRPM7-dependent Zn 2+ release from the vesicles, whereas reduced glutathione prevents TRPM7-dependent cytosolic Zn 2+ influx. These observations strongly support the notion that ROS-mediated TRPM7 activation releases Zn 2+ from intracellular vesicles after Zn 2+ overload. Like the endoplasmic reticulum, these vesicles are a distributed system for divalent cation uptake and release, but in this case the primary divalent ion is Zn 2+ rather than Ca , an ion channel and cytoplasmic kinase, is ubiquitously expressed and essential in early embryonic development (1-4) but also may mediate oxidative stress-induced anoxic neuronal death in adults (5, 6) . As an ion channel, TRPM7 conducts Zn 2+ >Mg 2+ ∼ Ca 2+ and monovalent cations (7-10) and contributes to labile cytosolic and nuclear Zn 2+ concentrations (8) . TRPM7's C-terminal kinase can phosphorylate multiple substrates (11) (12) (13) and is cleaved to release a proapoptotic, chromatin-modifying enzyme (8, 14) . Zn 2+ regulates TRPM7's kinase activity (11) and binding to transcription factors (8) . It is a potent signal for many cellular processes previously related to TRPM7 function, including gene expression, mitosis, and cell survival, but is also proapoptotic at extreme concentrations (15) (16) (17) (18) .
TRPM7 has been proposed to regulate intracellular Mg 2+ levels (19) . However, as we have shown, Trpm7 −/− cells have normal total magnesium concentrations (3, 14) , with the many abundant magnesium transporters (20) probably accounting for normal Mg 2+ homeostasis. Under physiological conditions, plasma membrane TRPM7's inward conductance is miniscule (<10 pA/pF at −100 mV), but it increases over minutes if the free cytosolic Mg 2+ concentration falls below its normal level of ∼0.5-1 mM (21) . Because in most cells the primary buffers for Mg 2+ are phosphonucleotides (22) , the metabolic state potentially regulates TRPM7 activity as ATP levels rise and fall around 0.5 mM. Under normal circumstances, the driving force for Mg 2+ entry into cells is relatively low ( ] in organelles and the cytosol (23) . TRPM7's Zn 2+ conductance suggests that it could support rapid changes in cytoplasmic Zn 2+ levels under the right circumstances, either across the plasma membrane or from intracellular compartments.
Oxidative stress increases inward divalent ion permeation through TRPM7 (5, 9), whereas acute and chronic oxidative stress in culture (24) (25) (26) or during ischemia-reperfusion in vivo (27, 28) induces TRPM7 expression. The resulting increase in cytosolic Zn 2+ could result in toxic cytosolic concentrations (9) . Conversely, reduction of TRPM7 expression protects animals from postischemia reperfusion (5), a condition typically accompanied by increased reactive oxygen species (ROS) and Zn
2+
release from intracellular stores (29) . Physiological redox transitions required for stem cell differentiation and gene expression during embryonic development (30, 31) may also be sensed by TRPM7 and transduced via Zn -dependent signals (32) . Because TRPM7 patch-clamp recording is limited to the plasma membrane, the assumption has been that TRPM7's main function is on the plasma membrane. However, we have previously shown that TRPM7 is also on intracellular membranes (33) (34) (35) . Indeed, ROS activation of divalent ion influx through TRPM7 (5, 9) is reminiscent of ROS activation of TRPM2, which releases Ca 2+ and Zn 2+ from lysosomes (36, 37 uncharacterized vesicles (M7Vs) that are distinct from familiar organelles. These vesicles sequester Zn 2+ during cytosolic overload. We show that the intravesicular M7V environment is reducing and that oxidation induces TRPM7-dependent Zn 2+ release from these vesicles. We hypothesize that TRPM7-mediated Zn 2+ release from intracellular stores regulates ROS signaling events during embryonic development or postnatal stress/injury.
Results

TRPM7
Is Most Abundant on Intracellular Vesicles. Whole-cell patchclamp measurements of endogenous and ectopically expressed TRPM7 establish that it is present in the plasma membrane (1, 2) . As with many ion channels that are relatively sparse, ectopically expressed TRPM7 was undetected at the plasma membrane by immunocytochemistry (Fig. 1A) . Instead TRPM7 was detected largely in intracellular vesicles ( Fig. 1 A-E) in multiple cell types. To rule out TRPM7 mislocalization artifacts caused by ectopic overexpression, we used a gene-trap strategy to insert GFP at the N terminus of endogenous TRPM7 in mouse ES cells. Expression of full-length GFP-TRPM7 was confirmed by immunoprecipitation of TRPM7 using either anti-GFP or anti-TRPM7, followed by Western blotting (Fig. S1A ). Endogenous GFP-TRPM7, visualized by immunostaining with anti-GFP antibody, was abundant in intracellular vesicles similar in size and distribution to TRPM-positive vesicles in cells ectopically expressing TRPM7 (Fig. 1F) . We also coimmunostained cells for GFP (TRPM7) and β-actin, which lines the inner leaflet of plasma membrane (38) , and imaged the localization of both proteins by stimulated emission depletion (STED) microscopy. β-Actin was concentrated at the cell periphery in a punctate distribution at the plasma membrane, whereas TRPM7 was detected in ∼100-nm vesicles located only on the cytoplasmic side relative to β-actin (Fig. 1B) .
To determine the intracellular localization of TRPM7 in detail, we carried out transmission electron microscopy (TEM) of anti-GFP-labeled HEK293 cells expressing TRPM7 with a pHsensitive GFP (pHluorin) (39) inserted into the S1/2 loop. Insertion of tags into the S1/2 loop did not compromise TRPM7 channel function (Fig. S2) . TEM revealed unilamellar vesicles with an average diameter of ∼150 nm specifically labeled with anti-GFP (Fig. 1C and Fig. S1 B and C) . The luminal anti-GFP labeling demonstrates the expected membrane orientation of TRPM7 polypeptide with the S1/2 loop in the lumen and the N and C termini in the cytosol (Fig. 1C) . Imaging of live cells Fig. S1 and Movie S1).
expressing the pHluorin-tagged TRPM7 established that the vesicles are acidic (Fig. S1D) . Total internal reflection (TIRF) microscopy of GFP-tagged TRPM7 in live SV40MES-13 cells also revealed TRPM7 localization in vesicles (Movie S1). Thus, under all conditions examined, TRPM7 channels are located primarily on abundant intracellular vesicles with comparatively fewer numbers on the plasma membrane.
M7Vs Are Distinct from Well-Characterized, Membrane-Bound Intracellular Compartments. To determine whether M7Vs are simply in route to the plasma membrane via classical secretory pathways, we assessed the colocalization of TRPM7 and GFP-tagged vesicular stomatitis virus protein (VSVG-GFP) (40) . TRPM7 did not colocalize with VSVG-GFP in transport vesicles in the cytoplasm or at the plasma membrane ( Fig. 2A) . Moreover, the vesicles did not colocalize with markers of several known cellular compartments, including calnexin, D1ER, Sec61β (endoplasmic reticulum; ER), PEX19, RFP-PTS (immature and mature peroxisomes), lamp1 (lysosomes), clathrin (endosomes), edem1 [EDEMosomes, ER-derived ERAD-tuning vesicles (41) ], ergic-53 (ER-Golgi intermediate compartments), and tyrosinase (melanosomes) (Fig. 2B ). M7Vs are also smaller and more abundant than zincosomes, ∼1-μm-wide vesicles that fluorescence brightly upon cellular Zn 2+ overload (42) . From their morphology, lack of markers, and lack of fusion with the plasma membrane by various stimuli (34), we surmise that M7Vs are previously uncharacterized intracellular membrane compartments.
Purification of M7Vs. Sucrose gradient fractionation confirms that endogenous TRPM7 is predominantly intracellular because it migrates as a peak distinct from the plasma membrane marker Na + /K + ATPase (Fig. 3A) . To probe the cellular function of TRPM7 vesicles, we isolated TRPM7-containing vesicles from postnuclear supernatants (PNS). We first tagged the C terminus of TRPM7 with an HA epitope and pulled down M7Vs with anti-HA-conjugated magnetic nanoparticles. The pulldown appears specific, because excess HA peptide blocked vesicle binding, the vesicles colocalized with nanoparticles, and the vesicle preparation was depleted of contaminating mitochondrial and endoplasmic reticulum markers (Fig. 3 ). We performed a second affinity purification of vesicles by N-terminal FLAG tag after elution of anti-HA-bound vesicles for proteomic analysis (Fig. S3A) . The affinity binding of the vesicles via tags located on the N and C terminals supports our earlier conclusion that the termini of TRPM7 face the cytoplasm. The substantial reduction of ER and mitochondria ( Fig. 3D and Fig. S3A ) supports the conclusion that TRPM7 vesicles are distinct from these structures.
The M7V Proteome. TRPM7 was enriched in the vesicle proteome, with a SILAC (stable isotope labeling with amino acids in cell culture) ratio of 56 in HEK293 cells and 98 in SV40MES-13 cells (Dataset S1). Proteins in known cellular compartments such as mitochondria, Golgi, and ER were present in the vesicle proteome, but ∼60% of the proteome was not classified in the Panther System (Dataset S1). We then screened the unclassified candidate proteins as potential markers for M7Vs and observed colocalization of M7Vs and vesicular integral membrane protein-36 (VIP36, also known as "LMAN2") ( , and loaded the vesicles with FluoZin-3-AM. FluoZin-3 fluorescence increased to saturation over 10 min and remained at these levels after the extravesicular fluorophore was washed out (Fig. 4 E and F (Fig. S5A) . The calculation of Zn 2+ concentrations using the binding constant suggests that the vesicles contain <0.1 nM free Zn 2+ under resting conditions. To rule out any possible effects of vesicular pH on the sensor's Zn 2+ affinity, we showed that neutralization of the vesicular lumen with NH 4 Cl did not increase FRET (Fig. S5B) . In contrast to M7Vs, ER-localized Sec61β-eCALWY4 (Fig. 5C) ] to >4 nM (τ = 104 ± 4 s) ( Fig. 5G ; see also ref. 49) , followed by slower vesicular uptake (τ = 503 ± 90 s) (Fig. 5G) . Vesicular Zn 2+ entry continued after influx was stopped by extracellular Zn 2+ chelation with EGTA (Fig. 5H) . We also targeted a recently developed intensiometric Zn 2+ sensor, ZnGreen1 (51) , to the M7V lumen by inserting it into the S1/2 intraluminal loop of TRPM7. M7Vs containing ZnGreen1 did not contain TPEN-chelatable Zn 2+ ( Fig. S5C) S5 E and F) . ZnGreen1-tagged TRPM7 channels were also functional (Fig. S2A) .
To test whether vesicles in intact cells retain loaded Zn
2+
, we took advantage of the low Zn 2+ affinity and wide dynamic range of ZnGreen1 (Fig. S5 E and F) , enabling us to monitor changes in Zn 2+ that otherwise would saturate eCALWY sensors (47) . As shown in Fig. S5 D-F , elevation of extracellular [Zn 2+ ] to 500 μM elevated cytosolic and M7V [Zn 2+ ] to >40 nM, saturating ZnGreen1. When cells were allowed to recover for 15 min in culture medium at 37°C (Fig. 5J) , cytosolic ZnGreen1 fluorescence was no longer saturated, but the vesicular sensor remained saturated ( Fig. 5 K and L) . These results indicate that Zn 2+ was enriched in M7Vs relative to the cytoplasm.
To examine whether divalent cation retention in M7Vs was selective for Zn 2+ , we also imaged Ca 2+ uptake and release from M7Vs in situ using GCaMP6s (52) . This probe was also inserted in the S1/2 loop of TRPM7 ( Fig. S4 C and D) and did not alter channel function (Fig. S2B) . The addition of 100 μM ATP to intact cells triggered Ca 2+ spikes in M7Vs that were synchronous with ER Ca 2+ release (simultaneously monitored with the red fluorescent, ER-targeted Ca 2+ sensor, RCEPIAer) ( Fig. S4C ) (53) or cytosolic spikes (simultaneously monitored with cytosolic red fluorescent R-GECO1) (Fig. S4D) (54) . The equilibration of Ca 2+ between the cytosol and M7Vs is consistent with the lack of Ca 2+ trapping in vesicles in vitro (Fig. S4A) Table S1 for additional description of markers.
earlier immunostaining observation that the vesicles are distinct from the ER. Thus, TRPM7 localizes to vesicles that selectively sequester Zn 2+ upon cytosolic Zn 2+ overload.
M7Vs Are Enriched in Glutathione. To search for clues about M7Vs' function, we identified metabolites in isolated M7Vs by HPLC-MS. Only glutathione (GSH) was substantially enriched in M7Vs affinity-purified from HEK293 or HEK293T cells, compared with total postnuclear membranes (Dataset S2). We verified the GSH enrichment using a GSH luciferase assay in endogenous vesicles tagged with an HA-epitope inserted at the N terminus of endogenous TRPM7 (Methods). After HA-TRPM7 expression in the ES cells was validated with immunoprecipitation and Western blotting (Fig. S6A ), vesicles were affinity purified with anti-HA nanoparticles (Fig. S6B) using the optimized method shown in Fig. 3 B and D. Total GSH was enriched sevenfold in M7Vs compared with total postnuclear membranes (Fig. 6A) . Given the central role of GSH in cellular redox reactions, we next determined the redox state of M7Vs in situ using the redox sensor roGFP2 (55) targeted to M7Vs. Although ∼10% of cytosolic roGFP2 was oxidized ( Fig. 6 B and C) , close to the ∼5% reported previously (56), ∼30% of roGFP2 was oxidized in M7Vs ( Fig. 6 B and C) . This percentage is significantly greater than the percentage of oxidized roGFP in the cytosol or in mitochondria (∼11%) (55) but is much lower than the 96-97% observed in the ER lumen (57, 58) or endolysosomes (94-97%) (57).
Reduced GSH Inhibits Zn 2+ Passage Through TRPM7. The observation of GSH enrichment in M7Vs motivated us to test whether GSH affects ion conductance through TRPM7. We measured plasma membrane TRPM7 because the extracellular medium can be altered readily to model the M7V lumen. First, Zn 2+ entry was measured using cytosolic eCALWY4 (Fig. 6D) . Overexpression of TRPM7 tripled the rate of Zn 2+ influx from the extracellular medium, whereas a control, nonconducting TRPM7 pore mutant (33) did not enhance Zn 2+ influx (Fig. 6 E and F) . The addition of 1 mM GSH, but not glutathione disulfide (GSSG), blocked the TRPM7-dependent Zn 2+ influx (Fig. 6 G and H) (Fig. 6 E-H) but also blocks both inward and outward monovalent TRPM7 currents with an IC 50 of ∼110 μM (Fig. S7 A-C) . We conclude that GSH likely prevents Zn 2+ entry into the TRPM7 pore, an inference supported by patch-clamp experiments demonstrating that GSH, but not GSSG, enhances monovalent TRPM7 currents (Fig. S7E) Fig. 5) , and monitored the increase in the mCitrine:mCerulean FRET ratio upon H 2 O 2 treatment in Zn 2+ -free extracellular medium. Exposure to 100 μM H 2 O 2 resulted in a gradual increase of FRET (i.e., a reduction in Zn 2+ ) in the M7V lumen, which reached a plateau in ∼30 min (Fig. 7A ). The ; then extravesicular dye was washed off, and remaining vesicular fluorescence was reduced by Zn 2+ chelation by membranepermeant TPEN but not membrane-impermeant EGTA. Fluorescence intensities in F were normalized to those in TPEN. Results are shown as the mean and SD from three experiments are shown; *P < 0.05; ANOVA. See also Fig. S4 A and 
FRET increase was substantially reduced in TRPM7
−/− cells compared with WT cells (Fig. 7 B and C) , indicating that TRPM7 mediates oxidation-induced Zn 2+ release from vesicles. The initial reduction of the FRET ratio of the Zn 2+ -saturated sensor by H 2 O 2 ( Fig. 7 A and B) (Fig. 7 D-F) . Because the extracellular solution did not contain significant Zn 2+ (<0.2 nM), we conclude that the source of the TRPM7-dependent, H 2 O 2 -induced increase in cytosolic Zn 2+ was the M7V. Finally, we tested whether endogenous ROS generation triggered by oxygen-glucose deprivation (OGD) (63, 64) elicits Zn 2+ release into the cytosol through TRPM7. OGD with glucosefree sodium dithionite resulted in a wave of Zn 2+ release, as recently reported (62) , in WT but not in TRPM7 −/− HEK293T cells (Fig. 7 G-I) . The OGD-induced Zn 2+ release was rescued by ectopic TRPM7 expression in TRPM7 −/− cells (Fig. 7I) . Again, because the extracellular solution did not contain significant Zn 2+ , we conclude that M7Vs were the source of TRPM7-dependent, OGD-induced increase in cytosolic Zn 2+ . In conclusion, TRPM7 forms functional intracellular channels that mediate Zn 2+ release from the lumen of a previously unrecognized population of vesicles during oxidative stress.
Discussion
Our prior observations of intracellular TRPM7 on 50-to 250-nm vesicles led us to investigate the existence of an additional and perhaps more important function of TRPM7 as an intracellular channel. Here we show that most TRPM7 forms intracellular , whereas TRPM8 may release Ca 2+ from the ER in some cell types (65, 66) . The Drosophila TRPM channel, proposed to release Zn 2+ from intracellular stores during larval development, exhibits TRPM7-like currents (67) . We now include TRPM7 in the class of functional intracellular TRP channels. However, the intracellular function of TRPM7 is unique in two ways. First, TRPM7 functions in vesicles that are distinct from known compartments. Second, unlike ER and lysosomes that store both Ca 2+ (68) . The complex dynamics of cellular redox status and M7V GSH content, cytoplasmic free Mg 2+ , and ATP (as well as other phosphonucleotides) will require careful examination in the future.
M7Vs are uniformly distributed in the cell and thus are an ideal ion storage system. We hypothesize that M7Vs sequester Zn 2+ to protect other organelles, but because Zn 2+ binds many proteins, DNA, and RNA, the vesicles also could release Zn 2+ to alter many cellular processes. We are exploring the possibility that Zn 2+ released from M7Vs regulates TRPM7 kinase cleavage, activity, or trafficking. Furthermore, the proteomics data in this study suggest that dozens of proteins are localized, at least partially, in M7Vs. In this study, we focused on iden- tifying probes for the lumens of M7Vs, but verification of the full complement of M7V proteins will elucidate their biogenesis and function. The presence of vesicle trafficking proteins (e.g., vesicle-associated membrane protein A, VAPA) and fusion proteins (e.g., vesicle-associated membrane protein 1, VAMP1, and extended syntaptotagmin-1, ESYT1) in the M7V proteome is consistent with the previously reported M7V exocytosis during shear stress and cholinergic synaptic transmission (33, 34) . Enrichment of ferritin light chain in vesicles isolated from SV40MES cells also suggests the possibility of iron storage by M7Vs. Our M7V proteome did not contain transporters for divalent cations (e.g., ZnTs, ZiPs, or other divalent metal transporters) or GSH, likely because these proteins are not highly expressed, but targeted proteomic analysis may reveal their identities. Total Zn 2+ increases by 50% during meiotic maturation of oocytes; about half of this increase is released by vesicular exocytosis within minutes of fertilization (69) , and the rest persists through preimplantation (70) . Because TRPM7 is required for preimplantation development (71), it will be important to determine if the Zn 2+ -containing vesicles in oocytes and early embryos are M7Vs and how changes in GSH/redox during early development (31, 72, 73) (16, 17, 74) , comparable to the levels required to fill M7Vs in these studies. Zn 2+ also may be redistributed from other intracellular sites into M7Vs. These include mitochondria and NADPH oxidase at the plasma membrane, major sites of ROS that liberate Zn 2+ from the mitochondrial matrix and from metallothioneins (16, 17, 74) . Thus, M7Vs may comprise a sink or reservoir buffering cytosolic Zn 2+ .
Experimental Procedures
Detailed methods are available in SI Experimental Procedures.
Immunofluorescence Microscopy. Cells were fixed in 4% paraformaldehyde and permeabilized in 0.1% Triton-X 100 at room temperature. Nonspecific binding was blocked with 10% goat serum in PBS, and cells were incubated in primary antibodies for 2 h at room temperature or overnight at 4°C, followed by detection with fluorophore-conjugated secondary antibodies. Cells then were imaged by confocal or STED microscopy.
TEM. Transfected cells were fixed in 1% paraformaldehyde in PBS, permeabilized, blocked, and incubated with anti-GFP antibody overnight. After rinsing, cells were labeled with protein-A-conjugated 10-nm colloidal gold (Aurion) or 1.4-nm FluoroNanogold-conjugated secondary antibodies (Nanoprobes); the latter were silver enhanced. Cells then were postfixed in 1% glutaraldehyde, and 10-nm-thin slices were imaged by TEM.
Tagging of Endogenous TRPM7. TRPM7 was tagged as described in ref. 75 . Briefly, ES cells with gene-trapped TRPM7 were purchased from the European Mammalian Mutant Cell Repository (EuMMCR) and verified by genotyping the regions flanking exon 1 of TRPM7. The cells then were electroporated with plasmids encoding GFP or HA-SNAP tags and flippase (FLP) recombinase. ES cell clones with tagged TRPM7 were selected with hygromycin.
Affinity Purification of TRPM7-Containing Vesicles. SV40MES-13 cells stably expressing GFP-TRPM7-HA or HEK293 cells stably expressing GCaMP6s-TRPM7-HRV3C-HA were homogenized and centrifuged to obtain PNS. The PNS was incubated with mouse anti-HA-conjugated magnetic nanoparticles (Miltenyi Biotec) and were loaded onto LS columns (Miltenyi Biotec). After rinsing, immobilized vesicles were eluted in PBS. For proteomic analysis eluted vesicles were isolated again with anti-FLAG-conjugated magnetic nanoparticles.
Metabolomics. M7Vs were isolated from HEK293 or HEK293T cells stably expressing GCaMP6s-TRPM7-HA using anti-HA nanoparticles as described above. They then were vortexed in 0.9% NaCl and centrifuged; supernatants were used for LC-MS sample extractions. Live Imaging of Vesicular Redox Environment. A ratiometric redox sensor, roGFP2, was targeted to the lumen of M7Vs by insertion between the S1 and S2 domains of TRPM7. After baseline image acquisition, the sensor was maximally reduced with 10 mM DTT (Bio-Rad) and then maximally oxidized in 1 mM diamide (Sigma). The cells then were perfused with 10 mM sodium dithionite (in glucose-free) or 100 μM H 2 O 2 (in normal) HBT-A medium containing 0.25 mM EGTA to chelate Zn 2+ and 4 mM Mg 2+ to block plasma membrane-localized TRPM7.
Imaging of
TRPM7 Deletion in HEK293T Cells. A variant of the CRISPR/Cas9 method (76) was used to insert puromycin-and blasticidin-coding sequences into the second exon of Trpm7. The donor DNA contained the predicted coding sequence of Trpm7's first 12 amino acids followed by an antibiotic resistance cassette, multiple stop codons, and SV40-polyA. Oligonucleotides encoding the genomic RNA (gRNA) sequence were annealed and cloned into BPK1520 (77) . Donor DNA containing puromycin-SV40pA and blasticidin-SV40pA cassettes were amplified from pPur (Clontech) and pcDNA6-V5-His (Invitrogen), respectively, with primers flanked with a target site on exon 2 of TRPM7 and were ligated into a pJET1.2 cloning vector (Thermo Fisher). HEK293T cells then were transfected with the BPK1520 construct and the puromycin resistance cassette donor template using Lipofectamine LTX (Thermo Fisher). Puromycin-resistant cells were cloned and genotyped, and knockout of Trpm7 was verified by immunoprecipitation, Western blotting, and electrophysiology.
Statistical Analyses. Data were plotted and analyzed in Prism 5 (GraphPad) by Student's t tests, ANOVA with Tukey's post hoc tests, or extra sum of squares F-tests (for nonlinear regressions).
